By
Adrianne Appel2023-02-23T22:03:00
It is still too early in the rulemaking process to know what will be included in the Biden administration’s final rule on transparency of nursing home ownership, but there are some steps facilities can take to prepare, according to experts.
The rule, proposed by the Department of Health and Human Services (HHS) on Feb. 15, would require nursing homes to disclose more information to the Centers for Medicare and Medicaid Services (CMS) about their ownership and operations, particularly concerning private equity ownership and any relationships with real estate investment trusts (REITs).
“The policy started from the assumption that there is a problem with REITs and private equity and corporate-owned nursing homes,” said J. Malcolm DeVoy, a partner at law firm Holland & Hart.
2023-04-17T19:57:00Z By Adrianne Appel
Some U.S. hospitals are falling short in protecting themselves from cyberattacks, with 29 percent of facilities recently surveyed lacking a documented GRC system, a new report from the Department of Health and Human Services found.
2023-02-28T20:20:00Z By Adrianne Appel
The Department of Health and Human Services and its office responsible for enforcing health privacy reorganized so it can sharpen enforcement of cybersecurity and data breaches.
2023-02-21T22:18:00Z By Adrianne Appel
The number of compliance reviews by the Department of Health and Human Services of health organizations increased between 2017 and 2021, according to the agency’s latest reports to Congress.
2025-12-10T15:30:00Z By Neil Hodge
For the past decade, Europe has led in creating strong but flexible rules for data use and safe AI development. The EU’s new plans to simplify key data privacy and AI governance measures have received a mixed response.
2025-12-05T19:25:00Z By Oscar Gonzalez
The U.S. Securities and Exchange Commission’s (SEC) Division of Examinations released its 2026 examination priorities, which give companies a roadmap of areas of heightened risk and regulatory focus for next year.
2025-12-04T22:15:00Z By Ruth Prickett
Regulation is a matter of life and death in the pharmaceutical industry. Rules to combat practices that can kill have been in force for decades, but tech developments are rapidly creating new risks and focusing lawmakers’ attention on areas where some compliance teams may lack experience.
Site powered by Webvision Cloud